Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alina Iovleva

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Clinics in Laboratory Medicine|May 2, 2017
Carbapenem-Resistant EnterobacteriaceaeAlina Iovleva, Yohei Doi
Drugs|November 28, 2024
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii InfectionsAlina Iovleva, Vance G Fowler, Yohei Doi
Journal of Travel Medicine|May 19, 2017
The ecology of extended-spectrum β-lactamases (ESBLs) in the developed worldYohei Doi, Alina Iovleva, Robert A Bonomo
Microbiology Spectrum|November 10, 2021
<i>In Vitro</i> Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirAChristi L McElheny, Erin L Fowler, Alina Iovleva, et al.
Genome Medicine|March 5, 2016
Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatmentMeredith S Wright, Alina Iovleva, Michael R Jacobs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to CefepimeRyan K Shields, Alina Iovleva, Ellen G Kline, et al.
Expert Review of Anti-Infective Therapy|January 10, 2018
Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapyNadim G El Chakhtoura, Elie Saade, Alina Iovleva, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2020
Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in <i>Enterobacter cloacae</i> Due to AmpC R2 Loop DeletionAkito Kawai, Christi L McElheny, Alina Iovleva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2022
Evolution and Transmission of Cefiderocol-Resistant Acinetobacter baumannii During an Outbreak in the Burn Intensive Care UnitSteven M Smoke, Alison Brophy, Samuel Reveron, et al.
Emerging Infectious Diseases|October 20, 2020
KPC-3-Producing Serratia marcescens Outbreak between Acute and Long-Term Care Facilities, Florida, USAAdriana Jimenez, Lilian M Abbo, Octavio Martinez, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Clinics in Laboratory Medicine|May 2, 2017
Carbapenem-Resistant EnterobacteriaceaeAlina Iovleva, Yohei Doi
Drugs|November 28, 2024
Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii InfectionsAlina Iovleva, Vance G Fowler, Yohei Doi
Journal of Travel Medicine|May 19, 2017
The ecology of extended-spectrum β-lactamases (ESBLs) in the developed worldYohei Doi, Alina Iovleva, Robert A Bonomo
Microbiology Spectrum|November 10, 2021
<i>In Vitro</i> Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirAChristi L McElheny, Erin L Fowler, Alina Iovleva, et al.
Genome Medicine|March 5, 2016
Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatmentMeredith S Wright, Alina Iovleva, Michael R Jacobs, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to CefepimeRyan K Shields, Alina Iovleva, Ellen G Kline, et al.
Expert Review of Anti-Infective Therapy|January 10, 2018
Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapyNadim G El Chakhtoura, Elie Saade, Alina Iovleva, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2020
Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in <i>Enterobacter cloacae</i> Due to AmpC R2 Loop DeletionAkito Kawai, Christi L McElheny, Alina Iovleva, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2022
Evolution and Transmission of Cefiderocol-Resistant Acinetobacter baumannii During an Outbreak in the Burn Intensive Care UnitSteven M Smoke, Alison Brophy, Samuel Reveron, et al.
Emerging Infectious Diseases|October 20, 2020
KPC-3-Producing Serratia marcescens Outbreak between Acute and Long-Term Care Facilities, Florida, USAAdriana Jimenez, Lilian M Abbo, Octavio Martinez, et al.
Pageof 3